The 6th Gene Therapy Analytical Development & CMC Summit will unite 250+ analytical development, CMC, QC, and process development experts to showcase innovative analytical and process development ...

--Lexeo Therapeutics, Inc., a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, announced today that new data supporting its AAV ...

New collaborations expand Takeda’s commitment to pursue the discovery of novel cell therapy approaches to treat blood cancers and solid tumors January 03, 2019 08:00 AM Eastern Standard Time ...

For example, the cost of a single dose of Novartis’ CAR-T cell therapy was set at $475,000, which puts them out of reach for many who need them most.

Alexis Bossie, Director, Cell Culture Media R&D, Bioscience, Lonza, added: “Lonza is renowned for its cell culture expertise, being one of the first companies to have its cell culture solutions used ...

A variety of reasons why an effective Chemistry Manufacturing & Controls (CMC) regulatory strategy for biopharmaceuticals can be a secret: (1) job security, especially for regulatory affairs personnel ...

Prior cost-effectiveness analyses comparing CAR T-cell therapy to chemotherapy estimate a $350,000 to $490,000 cost increase compared with salvage chemotherapy, with approximately 2 to 8 years of ...